Article
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
BMC cancer - 13 Jun 2022
van Schooten Tessa Suzanne, Derks Sarah, Jiménez-Martí Elena, Carneiro Fatima, Figueiredo Ceu, Ruiz Erika, Alsina Maria, Molero Cristina, Garrido Marcelo, Riquelme Arnoldo, Caballero Carmelo, Lezcano Eva, O'Connor Juan Manuel, Esteso Federico, Farrés Judith, Mas José Manuel, Lordick Florian, Vogt Jeannette, Cardone Antonella, Girvalaki Charis, Cervantes Andrés, Fleitas Tania
Abstract excerpt
BACKGROUND: Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor biology in European (EU) and Latin American (LATAM) countries is understudied. The LEGACy study is a Horizon 2020 funded multi-institutional research approach to 1) detail the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.